Ryan Cross is the Senior Science Correspondent at Endpoints News. He covers the science and technology behind new medicines, from preclinical research in academia to the untold stories behind recently commercialized products. His current areas of interest and focus include genetic medicines, neuroscience, new therapeutic modalities and emerging scientific fields.